This week, President Donald Trump said he's been taking the controversial anti-malaria drug, hydroxychloroquine, for nearly two weeks.
University Of Maryland Researchers Conduct Clinical Trials To Test Effectiveness, Safety Of Hydroxychloroquine
Credit: WJZ Baltimore
Duration: 02:33s
0 shares
1 views